The COVID-19 pandemic has not materially hurt cannabis producer Tilray Inc.’s ability to sell pot to medical patients and recreational customers, the company said late Monday as it reported a wider-than-expected net loss. Shares of Tilray TLRY, +3.85% fell 1.9% in the extended session after closing up 3.9% to close at $8.08 in Monday trading. The stock has […]